Actimed Therapeutics Successfully Closes Second Tranche Of £10M Seed Financing To Progress Pipeline For Treatment Of Cancer Cachexia And Other Muscle Wasting Disorders
Amount Raised
£10 Million
Round Type
Seed
Description
Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia, a significant unmet medical need for cancer patients, and other muscle wasting disorders announces completion of its second and final £5 million tranche of seed financing. The round was closed with an investment by Indian pharmaceutical company, Mankind Pharma, marking Mankind's first overseas investment of this type.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Actimed Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- HBM Alpha Therapeutics raised an undisclosed amount (Seed) on January 26, 2023.
- Pathos AI raised $20M on February 17, 2023.
- Rhaeos raised $11M (Series A) on February 16, 2023.
- Previa Medical raised $2.2M (Seed) on February 16, 2023.
- Alpha Cognition raised $1.8M (Seed) on February 16, 2023.
Who to call at Actimed Therapeutics, and when
A new round usually means Actimed Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Actimed Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actimed Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actimed Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actimed Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Actimed Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.